ON-TRK
PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
More Information
- Trial Status
- Accepting patients
- Enrollment
- 300 patients (estimated)
- Sponsors
- Bayer
- Tags
- Tyrosine Kinase (TK) Inhibitor
- Trial Type
- Observational
- Last Update
- 2 weeks ago
- SparkCures ID
- 1398
- NCT Identifier
- NCT04142437
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.